Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Date:10/30/2008

ncludes amortization expense related to purchased intangible assets

as well as amortization of the inventory step-up related to the

acquisition of the former Merck Generics business.

(3) Integration and other non-recurring expenses include charges

principally related to the acquisition and integration of the former

Merck Generics business (e.g., non-recurring professional and

consulting fees, retention and other non-recurring expenses).

(4) The tax effect is calculated assuming an annual effective tax rate for

the resulting adjusted earnings. This tax effect adjustment results in

an effective tax rate on adjusted earnings that approximates 38%

before the impact of any tax synergies.

Below is a reconciliation of GAAP net earnings (loss) to adjusted EBITDA for the three and nine months ended Sept. 30, 2008:

Three months ended Nine months ended

($'s in millions) September 30, 2008 September 30, 2008

GAAP net earnings (loss) $206.8 $(176.0)

Add/(Deduct):

Minority interest (0.2) (2.3)

Income from equity method

investees (0.5) (3.2)

Income taxes 272.4 197.4

Interest expense 87.6 264.8

Depreciation & amortization 131.5 417.4

EBITDA 697.6 698.1

Add/(Deduct) Adjustments:

Non-cash stock-based

compensation expense 7.6 23.2

Bystolic revenues (455.0) (468.1)

Integration and other non-

recurring expenses 26.8 91.3

Goodwill impairme
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
6. Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
7. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
8. Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 29, 2015   Veracyte, Inc . (Nasdaq: ... of molecular cytology, today announced that it has been ... Workplaces list for the second year in a row. ... on an annual survey of Bay Area-company employees. ... degree to which Veracyte values our employees and their ...
(Date:6/26/2015)... , June 26, 2015   Aratana ... a pet therapeutics company focused on the ... products for companion animals, today announced positive ... of capromorelin (AT-002), the company,s innovative therapeutic ... a small molecule that mimics ghrelin, the ...
(Date:6/26/2015)... MUMBAI, India , June 26, 2015  Tata ... global IT services, consulting and business solutions organization, announced ... Worldwide Life Sciences R&D Risk-Based Monitoring by global market ... Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment," (doc ... evaluated eight leading IT services vendors with significant RBM ...
(Date:6/26/2015)... -- The report "Biolubricants Market by Type ... Chainsaw oils, Mold Release Agents), End Use (Industrial, Commercial ... and Forecasts to 2020" published by MarketsandMarkets, The Biolubricants ... at a CAGR of 6.27% between 2015 and 2020. ...   66 Figures spread through 170 Pages and in-depth ...
Breaking Biology Technology:Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4Biolubricants Market Worth $2,972.13 Million by 2020 2Biolubricants Market Worth $2,972.13 Million by 2020 3
... Small Companies In America, UNION CITY, Calif., Oct. ... products company manufacturing point-of-care,blood chemistry analysis systems, announced today ... named "Entrepreneur of,the Year" by Forbes Magazine in its ... ranked eleventh of the "200 Best Small Companies in,America." ...
... Held by GlaxoSmithKline Since June 2006, PHILADELPHIA ... The Thomson Corporation (NYSE: TOC ; TSX: ... worldwide research and,business communities, today announced the availability ... on drugs and therapies. "Who is,Making the Biggest ...
... AURORA, ON, Oct. 15 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX: ... F. McElroy,has resigned as Chairman and a director of ... had a long involvement with the Company since its,amalgamation ... "On behalf of the Company, I thank him for ...
Cached Biology Technology:Abaxis CEO Clint Severson Named 'Entrepreneur of the Year' by Forbes Magazine 2Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007 2Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007 3Helix BioPharma Chairman resigns 2
(Date:6/23/2015)... , June 23, 2015   Valencell, ... the results of a recent study that illustrates ... the wrist during activity. In a study conducted ... compared along with the Apple Watch against a ... heart rate during activity. The study demonstrated that ...
(Date:6/17/2015)... , Deutschland und GERMANTOWN, Maryland , ... ®   Produktlinie mit DNA-Tests verbessert ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... neue STR-Testkits der Produktlinie Investigator ® ... den Markt eingeführt. Die neuen Kits zur Erstellung genetischer ...
(Date:6/16/2015)... QUEBEC CITY , June 16, 2015 /CNW ... announce their partnership centralized around the incorporation of ... mobile point-of-care diagnostic laboratory, the Mo-POD™. This unprecedented ... the BIO International Conference at the ... from June 15 th to ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... (BRONX, NY) More women are choosing science careers, ... because they abandon their careers due to pessimism about ... decision-making roles on the teams that organize symposia could ... have made dramatic gains in obtaining science degrees over ...
... 6, 2014) Of the 1.9 million species of creatures ... are invertebrates. They have served as model organisms in many ... important role of invertebrates in science including sea urchins for ... Loligo for neurobiology research, the fruit fly Drosophila ...
... , BERLIN and TELTOW, ... RED-n eye tracker by SensoMotoric Instruments, (SMI) brings robust, accurate ... at a mass market price to OEMs and consumer applications. ... The doors open at CES 2014 and SensoMotoric ...
Cached Biology News:Boost careers of female scientists: Make sure women help choose meeting speakers 2Boost careers of female scientists: Make sure women help choose meeting speakers 3New organization brings together top researchers to sequence the genomes of invertebrates 2New organization brings together top researchers to sequence the genomes of invertebrates 3SensoMotoric Instruments Unveils SMI RED-n Consumer Eye Control Technology for Gaming and Computing 2
MAb to Myoglobin Cardiac...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Cells are grown to a specified density and induced, when necessary. Protein expression samples are collected at 3 growth points and analyzed by SDS-PAGE/Coomassie....
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
Biology Products: